In today's competitive and time-sensitive environment, the ability to efficiently translate a promising molecule into a ...

From filming star-like plasma in trillionths of a second to testing a record-breaking lithium thruster and advancing 300kW-class missile defense lasers, researchers and engineers marked major leaps in ...

Q1 2026 earnings call recap: rebrand, revenue/EBITDA trends, guidance reaffirmed, margin/cash flow drivers, and buybacks—read more.

NewcelX and Eledon Pharmaceuticals are collaborating to advance one of the few scalable approaches to a potential functional cure in Type 1 ...

S&P Global Inc. today announced the Board of Directors for Mobility Global Inc. ("Mobility Global") following its planned separation from S&P Global into an independent, public company by ...

Kenvue Inc. (NYSE: KVUE) today announced financial results for the fiscal first quarter ended March 29, 2026.

First quarter results showed its order book swelling by US$18.3 billion, a growth of more than 70 per cent year on year. Read ...

Skyline Nav AI, headquartered in the Greater Boston Area, is changing the game with its Pathfinder technology that is making ...

Tanzania, like many countries in Africa, has fought malaria for generations. Our existing tools, from insecticide-treated ...

Issued on behalf of VisionWave Holdings, Inc., Starfighters Space, Inc., Avaí Bio, Inc., Lake Victoria Gold Ltd., and QSE – Quantum Secure ...

Good day, and thank you for standing by. Welcome to the Revolution Medicines Q1 2026 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now ...